DiGeorge Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome.
|
12810603 |
2003 |
Shprintzen syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome.
|
12810603 |
2003 |
Congenital Abnormality
|
0.030 |
Biomarker
|
group |
BEFREE |
Study of Chordin;Noggin mutant mice is helping us to understand the molecular, cellular, and genetic pathogenesis of HPE and associated malformations.
|
20104603 |
2010 |
Congenital Abnormality
|
0.030 |
Biomarker
|
group |
BEFREE |
Without it, lack of chordin results in a low penetrance of mandibular hypoplasia but no cardiac or thoracic organ malformations.
|
19247433 |
2009 |
Congenital Abnormality
|
0.030 |
GeneticVariation
|
group |
BEFREE |
We considered that the CHRD gene and the chordin-regulating GSC (goosecoid) gene could be candidate genes for Cornelia de Lange syndrome (CDLS), a developmental malformation syndrome which is primarily characterised by mental handicap, growth retardation, distinctive facial features and limb-reduction defects.
|
10480362 |
1999 |
Decompression Sickness
|
0.010 |
Biomarker
|
disease |
BEFREE |
To search for the common morphogenetic cue in these two species, we initially confirmed the expression patterns of the dorsal-ventral regulatory TGF-β members, nodal, lefty, bmp2/4, and chordin, in T. reevesii because these factors are appropriate candidates to investigate the cue that starts gut bending, although genetic information about the body axes is entirely lacking in this species.
|
29878318 |
2018 |
von Willebrand Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We also report that the von Willebrand type C domain of TSP-1 is likely responsible for this BMP-2/4-binding activity, an assertion based on sequence similarity that TSP-1 shares with the von Willebrand type C domain of Crossveinless 2 (CV-2), a BMP antagonist and member of the chordin family.
|
28747434 |
2017 |
Tumor Cell Invasion
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Thus, we treated HCC cells with the general BMP inhibitors chordin and noggin to determine the functional relevance of BMP overexpression and observed decreased migration and invasion of HCC cells.
|
22024355 |
2012 |
Holoprosencephaly
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Study of Chordin;Noggin mutant mice is helping us to understand the molecular, cellular, and genetic pathogenesis of HPE and associated malformations.
|
20104603 |
2010 |
Craniofacial Abnormalities
|
0.010 |
Biomarker
|
group |
BEFREE |
Thus, chordin is a modifier for the craniofacial anomalies of Tbx1 mutations, demonstrating the existence of a second-site modifier for a specific subset of the phenotypes associated with 22q11DS.
|
19247433 |
2009 |
22q11 Deletion Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Null mutations of chordin have been reported to cause severe defects recapitulating 22q11DS, which we show are highly dependent on genetic background.
|
19247433 |
2009 |
Aplasia/Hypoplasia of the mandible
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Without it, lack of chordin results in a low penetrance of mandibular hypoplasia but no cardiac or thoracic organ malformations.
|
19247433 |
2009 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
To determine the functional relevance of the absence of CHRD mRNA in tumors and cancer cell lines, we studied the effects of CHRD on two cancer cell lines, BG1 and PEO14.
|
16449796 |
2006 |
ovarian neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here we show that CHRD is underexpressed in epithelium ovary cancer and epithelial cancer cell lines as compared with normal tissues and OSE, respectively.
|
16449796 |
2006 |
Malignant neoplasm of ovary
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here we show that CHRD is underexpressed in epithelium ovary cancer and epithelial cancer cell lines as compared with normal tissues and OSE, respectively.
|
16449796 |
2006 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
To determine the functional relevance of the absence of CHRD mRNA in tumors and cancer cell lines, we studied the effects of CHRD on two cancer cell lines, BG1 and PEO14.
|
16449796 |
2006 |
Fibrodysplasia Ossificans Progressiva
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Basal and BMP-4-induced expression of noggin, gremlin, follistatin, and chordin mRNA were investigated in control and fibrodysplasia ossificans progressiva lymphoblastoid cell lines with use of reverse transcriptase-polymerase chain reaction and Northern analysis.
|
12672843 |
2003 |
Thrombocytopenia
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
The candidacy of the CHRD and GSC genes was supported by several lines of evidence: prior evidence for a CDLS gene at 3q26.3-q27; a report suggesting a significant association between CDLS and thrombocytopenia; suspected genetic heterogeneity in CDLS; location of the GSC gene in close proximity to a 14q32 breakpoint detected in a CDLS patient with a balanced de novo translocation; known regulation of chordin expression by goosecoid; and the pattern of embryonic expression of the mouse GSC gene.
|
10480362 |
1999 |
Cornelia De Lange Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The candidacy of the CHRD and GSC genes was supported by several lines of evidence: prior evidence for a CDLS gene at 3q26.3-q27; a report suggesting a significant association between CDLS and thrombocytopenia; suspected genetic heterogeneity in CDLS; location of the GSC gene in close proximity to a 14q32 breakpoint detected in a CDLS patient with a balanced de novo translocation; known regulation of chordin expression by goosecoid; and the pattern of embryonic expression of the mouse GSC gene.
|
10480362 |
1999 |
Mental handicap
|
0.010 |
Biomarker
|
disease |
BEFREE |
We considered that the CHRD gene and the chordin-regulating GSC (goosecoid) gene could be candidate genes for Cornelia de Lange syndrome (CDLS), a developmental malformation syndrome which is primarily characterised by mental handicap, growth retardation, distinctive facial features and limb-reduction defects.
|
10480362 |
1999 |